Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 4 Open-market buy Chief Executive Officer bought 6,000 shares at $7.50 ($45,000)
  2. 4 Open-market buy Director bought 25,000 shares at $7.50 ($187,500)
  3. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $7.50 ($7,500)
  4. 4 Open-market buy Director bought 10,000 shares at $7.50 ($75,000)
  5. 4 Open-market buy Director bought 6,000 shares at $7.50 ($45,000)
  6. 4 Open-market buy Chief Medical Officer bought 4,500 shares at $8.38 ($37,710)
  7. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $7.02 ($14,033)
  8. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $7.24 ($14,470)
  9. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.95 ($13,900)
  10. 4 Open-market buy Director bought 1,000 shares at $6.80 ($6,800)
  11. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.48 ($12,950)
  12. 4 Open-market buy Director bought 4,000 shares at $6.57 ($26,280)
  13. 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.27 ($12,530)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 19 · 376 filings